Loading...
NPI 1215995535 · Buffalo, NY · Neurology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Gil Wolfe is a neurology physician provider located in Buffalo, New York. This profile covers 10 Medicare and 4 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Gil Wolfe |
| Address | 1010 Main St |
| City | Buffalo |
| State | NY |
| ZIP | 14202 |
| Taxonomy | Neurology Physician |
| NPI Enumerated | May 3, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $37.6K |
| Medicaid | $540 |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
10 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| G0453 | Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in… | 890 | $20 | $21.4K |
| 95939 | The provider performs a central motor evoked potential study in the upper and lower limbs for diagnosis of multiple sclerosis and as a prognostic indicator for stroke motor recovery. | 40 | $90 | $3.7K |
| 95938 | In this procedure, the provider performs a short–latency somatosensory evoked potential study by stimulating the peripheral nerves or skin sites in both the upper limbs and lower limbs. The provider… | 110 | $30 | $3.6K |
| 95861 | In this procedure, the provider uses an electromyograph to record electrical activity that skeletal muscle cells produce while the provider inserts needles into the muscle during rest and while… | 40 | $60 | $2.7K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 20 | $130 | $2.3K |
| 95870 | In this procedure, the provider performs needle electromyography, which refers to the recording and study of electrical activity of muscles using a needle electrode. Use this code when the provider… | 80 | $20 | $1.2K |
| 95886 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction study. He studies five or more… | 30 | $40 | $910 |
| 95908 | In this procedure, the provider performs three or four nerve conduction studies, a diagnostic test to evaluate the function, especially the ability of electrical conduction of the motor and sensory… | 10 | $50 | $550 |
| 95822 | Electroencephalogram or EEG is a diagnostic test that uses small electrodes attached to the scalp to measure the electrical activity of the brain. In this procedure the provider performs the EEG when… | 10 | $40 | $470 |
| 95885 | The provider assesses the electrical activity of a muscle in the extremity and related paraspinal areas. At the same session as a separately reportable nerve conduction studies. The provider performs… | 30 | $10 | $450 |
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 10 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
4 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 20 | $20 | $360 |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 20 | $10 | $140 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 20 | $1 | $60 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 20 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
4 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 87 | 90 | 260 | $360 | $435.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 172 | 200 | 630 | $150 | $338K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 115 | 140 | 130 | $10 | $2K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 181 | 190 | 730 | $1 | $970 |
Other providers in the same ZIP code as Gil Wolfe, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Trusted Nurse Staffing | NY | Nursing Care Agency | $0 | $85.5M |
| Bestself Behavioral Health, Inc. | NY | Mental Health Clinic/Center (Including Community Mental Health Center) | $0 | $32.9M |
| Western New York Bloodcare, Inc. | NY | Clinic/Center | $1.3K | $12.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.